Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2017-04-10 | PAUL B. ROTHMAN, M.D. Independent Director Age: 59 Director since: 2015 Committees: Research 2016 Director Compensation: $306,000 |
| 2018-04-09 | Paul B. Rothman, M.D. Age 60 Director since: 2015 INDEPENDENT COMMITTEES: Audit Research 2017 DIRECTOR COMPENSATION Paul B. Rothman Fees Earned or Paid in Cash ($) 115,833 All Other Compensation ($) 196,000 Total ($) 311,833 |
| 2019-04-08 | PAUL B. ROTHMAN, M.D. INDEPENDENT AGE: 61 DIRECTOR SINCE: 2015 COMMITTEES: Audit Research 2018 DIRECTOR COMPENSATION Paul B. Rothman $125,000 Fees Earned or Paid in Cash $230,000 All Other Compensation $355,000 Total |
| 2020-04-06 | Dr. Rothman has extensive expertise in patient care, science and medicine relevant to the pharmaceutical industry, including through his positions as the CEO of Johns Hopkins Medicine and the Dean of Medical Faculty and Vice President for Medicine, The Johns Hopkins University, and his past experience as Dean and Head of Internal Medicine at Carver College of Medicine at the University of Iowa. In addition, his vast operational and management experience of a large-scale medical organization provide him with a deep understanding of the complexities of the U.S. healthcare delivery system and policy environment. |
| 2021-04-05 | Dr. Rothman has extensive expertise in patient care, science and medicine relevant to the pharmaceutical industry, including through his positions as the CEO of Johns Hopkins Medicine and the Dean of Medical Faculty and Vice President for Medicine, The Johns Hopkins University, and his past experience as Dean and Head of Internal Medicine at Carver College of Medicine at the University of Iowa. In addition, his vast operational and management experience of a large-scale medical organization provide him with a deep understanding of the complexities of the U.S. healthcare delivery system and policy environment. |
| 2022-04-04 | Dr. Rothman has extensive expertise in patient care, science and medicine relevant to the pharmaceutical industry. |
| 2023-04-03 | Dr. Rothman has extensive expertise in patient care, science and medicine relevant to the pharmaceutical industry, including through his past experiences as (a) the CEO of Johns Hopkins Medicine and the Dean of Medical Faculty and Vice President for Medicine, The Johns Hopkins University, and (b) Dean and Head of Internal Medicine at Carver College of Medicine at the University of Iowa. His vast operational and management experience leading a large-scale medical organization provide him with a deep understanding of the complexities of the U.S. healthcare delivery system and policy environment. |
| 2024-04-11 | Dr. Rothman has extensive expertise in patient care, science and medicine relevant to the pharmaceutical industry, including through his past experiences as (a) the CEO of Johns Hopkins Medicine and the Dean of Medical Faculty and Vice President for Medicine, The Johns Hopkins University, and (b) Dean and Head of Internal Medicine at Carver College of Medicine at the University of Iowa. His vast operational and management experience leading a large-scale medical organization provide him with a deep understanding of the complexities of the U.S. healthcare delivery system and policy environment. |
Data sourced from SEC filings. Last updated: 2025-08-30